Abvc Biopharma Inc (NQ: ABVC )
0.7151
+0.0051
(+0.72%)
Streaming Delayed Price
Updated: 3:48 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Abvc Biopharma Inc![]() ![]() Via NewMediaWire
Via TheNewswire.com
![]()
ABVC BioPharma Awarded ADHD Treatment Patent in Australia, a Potential $32 Billion Market
June 25, 2024
Via NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
![]() Via NewMediaWire
![]() ![]() Via NewMediaWire
![]() Via NewMediaWire
Via TheNewswire.com
![]() ![]() Via NewMediaWire
![]() Via NewMediaWire
Via TheNewswire.com
![]() ![]() Via NewMediaWire
Via TheNewswire.com
![]() ![]() ![]() ![]() ![]()
ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)
February 12, 2024
Via NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Abvc Biopharma Inc (NQ: ABVC )
0.7151
+0.0051
(+0.72%)
Streaming Delayed Price
Updated: 3:48 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Abvc Biopharma Inc
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|